| payload |
{"created_at":"2026-04-07T03:18:43.308 {"created_at":"2026-04-07T03:18:43.308311+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:1f34ad271411fde3","evidence_event_ids":["evt_ec6ebfacf3de"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","as_of":"2026-04-07T03:18:43.308311+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_6889fa15561d4c6f","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","content_type":"text/plain","enriched_at":"2026-04-07T08:17:51.005374+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt","source_event_id":"evt_ec6ebfacf3de","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"daa230e28d765dbf","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-02","2026-04-06"],"entities":[{"asset_class":"equity","name":"United Therapeutics Corp","relevance":"issuer","symbol":"UTHR","type":"company"},{"asset_class":"","name":"Martine A. Rothblatt","relevance":"reporting owner","symbol":"","type":"individual"}],"event_type":"listing","information_gaps":["No prior state of stock ownership or transactions disclosed for comparison."],"key_facts":["Form 4 filed on April 6, 2026.","Transactions occurred on April 2, 2026.","Martine A. Rothblatt is the Chairperson & CEO of United Therapeutics Corp.","The transactions were executed under a 10b5-1 trading plan."],"numeric_claims":[{"label":"Total shares sold","value":"1,734,410"},{"label":"Stock options exercised","value":"9,500"},{"label":"Price range of transactions","value":"$562.00 to $570.05"}],"primary_claim":"Martine A. Rothblatt executed multiple stock transactions involving United Therapeutics Corp's common stock on April 2, 2026, under a pre-arranged trading plan.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"United Therapeutics Corp filed a Form 4 on April 6, 2026, disclosing stock transactions by Martine A. Rothblatt, including the exercise of stock options and sales of common stock.","topics":["SEC Filing","Insider Trading","Stock Options"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260406","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000026.txt"}}... |